Results 131 to 140 of about 61,327 (250)

Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Cerebral Cortical Encephalitis: A Comparative Study With Antibody‐Negative and Non‐MOG Antibody‐Positive Cortical Encephalitis in Chinese Adults

CNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
MOG antibody‐associated cortical encephalitis (MOG‐CCE) presents a distinct clinical phenotype characterized by seizure‐dominant onset, unilateral cortical lesions, and favorable immunotherapy response, highlighting the diagnostic and prognostic value of antibody profiling in autoimmune cortical encephalitis.
Qing Yin, Binhong Han, Kai Su, Weiqi Dai, Jing Wu, Li Yang, Yuwei Dai, Dan Wang   +7 more
wiley   +1 more source

Clinical Image of Shingles

Journal of Clinical and Diagnostic Research
Shingles, clinically referred to as Herpes Zoster, is a viral dermatological condition that arises from the Varicella Zoster Virus (VZV). Following a prior varicella infection, this virus persists in an inactive state within the sensory ganglia ...
Pratiksha Mahure, Bharat Rathi, Bhagyashree Jibkate, Shubham Khanke   +3 more
doaj   +1 more source

A novel case of autosomal recessive CARD11 loss‐of‐function underlying impaired antiviral immunity and a review of literature

Clinical &Translational Immunology, Volume 15, Issue 5, 2026.
We report on a patient homozygous for a novel autosomal recessive loss‐of‐function CARD11 variant, with susceptibility to live attenuated virus (LAV) vaccines and impaired clearance of multiple naturally acquired respiratory viral infections. Inborn errors of immunity affecting the CARD11‐BCL10‐MALT1 (CBM) complex should be considered in individuals ...
Hamish Anderson, Cecilia Verryt, Paula Keating, Thomas Saunders, Samuel Dalton, Barry D Hock, Liping Goddard, Kylie Drake, Anja Werno, John O'Donnell, Jeffrey R Stinson, Andrew L Snow, Kuang‐Chih Hsiao   +12 more
wiley   +1 more source

Herpes Zoster Vaccine Awareness and Uptake Among Older Adults in Saudi Arabia: Insights for Public Health, Preventive Medicine, and Primary Care Practice

Journal of General and Family Medicine, Volume 27, Issue 3, May 2026.
ABSTRACT Background/Objectives Complications from Herpes Zoster (HZ) are common among older adults and immunosuppressed populations. The HZ vaccine is a clinically and financially superior alternative to antiviral medications. However, a knowledge gap exists within the population regarding HZ and the vaccine.
Adam F. Aldhawyan, Mohammed A. BuSaad, Hasan M. Alswiket, Abdullah M. Alradhi, Ryad F. Alamry, Fadel A. Almulla, Amjad Z. Boarish, Reema J. Alghamdi, Abdullatif K. Althunyan, Amani M. AlQarni   +9 more
wiley   +1 more source

Vaccination Rates in Patients with Chronic Inflammatory Skin Diseases and Immunomodulatory Systemic Therapies—Vaccinations against SARS-CoV-2, Influenza Virus or Varicella Zoster Virus

Life
Introduction: The national guidelines and the Standing Committee on Vaccination (STIKO) of the Robert Koch Institute (RKI) in Germany support preventive vaccinations for patients under immunomodulatory treatments.
Brigitte Stephan, Anna Meineke, Matthias Augustin, Christina Sorbe   +3 more
doaj   +1 more source

Varicella-zoster virus myeloencephalitis

IDCases, 2017
Matsuo, Takahiro, Mori, Nobuyoshi, Sakurai, Aki, Furukawa, Keiichi   +3 more
openaire   +2 more sources

Serological immunity against vaccine‐preventable diseases in children with inflammatory bowel disease at diagnosis

JPGN Reports, Volume 7, Issue 2, Page 289-295, May 2026.
Abstract Objectives Patients with inflammatory bowel disease (IBD) are at increased risk of vaccine‐preventable diseases. However, vaccination coverage in this population is often suboptimal. This retrospective study assessed the vaccination status and vaccine serology of children diagnosed with IBD in a high‐income country with broad vaccine access ...
Clara Noble, Renato Gualtieri, Klara Posfay‐Barbe, Nathalie Rock, Geraldine Blanchard‐Rohner   +4 more
wiley   +1 more source

A fresh look at varicella vaccination

Human Vaccines & Immunotherapeutics
The varicella vaccine is a live attenuated varicella zoster virus (VZV), first produced by Michiaki Takahashi (1974). Subsequent development of the fluorescent antibody to VZV membrane antigen test (FAMA), an immune correlate, permitted vaccine efficacy ...
Anne A. Gershon, Michael D. Gershon
doaj   +1 more source

Herb‐Based Extracellular Vesicles for Infectious Disease

Small Structures, Volume 7, Issue 5, May 2026.
Chinese herbal medicine‐derived extracellular vesicles‐like particles (CHM‐EVLPs) are presented as innovative nanomedicines for infectious diseases. This review highlights their diverse therapeutic effects, including pathogen clearance, immune modulation, microbiota regulation and tissue barrier repairment, unlocking a powerful natural material against
Erjia Weng, Zhi‐Chao Sun, Yuntao Liu, Ran Liao, Ran Lin, Yan Zhang, Xi Zhang, Minghua Tang, Kaichun Yang, Xiaolu Wang, Wen Huang, Zhongde Zhang, Xiaotu Xi, Jun Wu   +13 more
wiley   +1 more source

A Dose-Response Study of a Live Attenuated Varicella-Zoster Virus (Oka Strain) Vaccine Administered to Adults 55 Years of Age and Older [PDF]

, 2017
Decreased cell-mediated immune (CMI) response to varicella-zoster virus (VZV) is correlated with an increased risk of reactivation of latent virus from dorsal root sites, leading to herpes zoster.
Bailleux, Fabrice, Berger, Rosemarie, Creusvaux, Hervé, Holländer, Georges, Rudin, Christophe, Trannoy, Emanuelle   +5 more
core